Escalade Reports Strong Q4 Profitability, Significant Debt Reduction, and Dividend Increase
ESCA sits 23% above its 52-week low of $11.41.
Summary
Escalade reported strong Q4 2025 earnings with increased net income and EBITDA, significant debt reduction, and a higher quarterly dividend, despite a modest sales decline.
Key Events · Earnings and Guidance · ESCA
-
Strong Q4 Profitability
Net income rose to $3.7 million ($0.27/diluted share) from $2.7 million ($0.19/diluted share) in Q4 2024, with EBITDA increasing 9.3% to $6.5 million.
-
Significant Debt Reduction
Total debt decreased by 27.9% to $18.5 million, resulting in a net leverage of 0.3x trailing twelve-month EBITDA.
-
Increased Quarterly Dividend
The Board of Directors approved an increased quarterly dividend of $0.1525 per share, payable April 13, 2026, to shareholders of record on April 6, 2026.
-
Improved Gross Margins
Gross margin for Q4 2025 improved by 280 basis points to 27.7%, driven by improved operational efficiencies.
Analysis · ESCA · Manufacturing
Escalade delivered robust fourth-quarter results, marked by a substantial increase in net income and EBITDA, alongside a significant 27.9% reduction in total debt. Despite a slight decline in net sales, improved gross margins and operational efficiencies drove profitability. The Board's decision to increase the quarterly dividend reflects confidence in the company's cash generation and financial health, while recent acquisitions signal a focus on strategic growth.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1498 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ESCA was trading at $14.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $206M. The 52-week trading range was $11.41 to $16.99. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.